Literature DB >> 1090155

Hereditary complement (C2) deficiency with dermatomyositis.

J P Leddy, R C Griggs, M R Klemperer, M M Frank.   

Abstract

A 60 year old white man in previous good health presented with a 6 month history of progressive muscle weakness. Clinical and laboratory findings were typical of dermatomyositis. Muscle biopsy confirmed the presence of inflammatory myopathy; deposits of immunoglobulin G (IgG), immunoglobulin M (IgM) or third component of complement (C3) were not detected by immunofluorescence. No evidence was found for an associated neoplasm. An unexpected finding was the total absence of serum hemolytic complement activity. Further investigation revealed that the complement defect was attributable to a selective and total absence of the second component of complement (C2), as determined by both functional and immunoprecipitin assays. Family studies indicated that the defect was inherited in an autosomal recessive manner, as has been observed in the previously reported C2-deficient kindreds. This case demonstrates that typical muscle lesions of dermatomyositis can occur in the presence of a complement defect which would preclude activation of the classic (C1-C4-C2) complement pathway. The case is of further interest as one of a series of recently reported associations of rheumatic diseases with hereditary complement deficiencies. Study of the functional properties of the propositus' C2-deficient serum demonstrated normal generation of chemotactic activity in the presence of endotoxin or aggregated IgG, and normal or near normal bactericidal activity against Salmonella typhi O 901 and Hemophilus influenzae, type b. These findings emphasize the importance of the alternate (properdin) pathway of complement activiation in these functions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090155     DOI: 10.1016/0002-9343(75)90537-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  19 in total

1.  Dermatomyositis.

Authors:  L M Tierney
Journal:  West J Med       Date:  1976-04

2.  Serum immunogloblin levels in myasthenia gravis, polymyositis, and dermatomyositis.

Authors:  R P Lisak; B Zweiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-01       Impact factor: 10.154

3.  Editorial: Complement activation and disease.

Authors: 
Journal:  Br Med J       Date:  1976-02-21

4.  Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.

Authors:  S I Rosenfeld; M E Kelly; J P Leddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

Review 5.  Immunological features of polymyositis/dermatomyositis.

Authors:  W M Behan; P O Behan
Journal:  Springer Semin Immunopathol       Date:  1985

6.  Familial canine dermatomyositis. Initial characterization of the cutaneous and muscular lesions.

Authors:  A M Hargis; K H Haupt; G A Hegreberg; D J Prieur; M P Moore
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

7.  Inherited deficiency of the second component of complement. Rheumatic disease associations.

Authors:  D Glass; D Raum; D Gibson; J S Stillman; P H Schur
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

Review 8.  Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.

Authors:  R L Dawkins
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

9.  Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis.

Authors:  J L Roberts; M M Schwartz; E J Lewis
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

10.  Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study group.

Authors:  A El-Ghobarey; G Balint; K de Ceulaer; W C Dick; W W Buchanan; T Hadidi; T A Hassan
Journal:  Postgrad Med J       Date:  1978-08       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.